|
|
Antimicrob Agents Chemother. 1990 February; 34(2): 321–325. | PMCID: PMC171580 |
Tolerance and efficacy of parenterally administered penicillin-streptomycin and orally administered amoxicillin or penicillin V for prophylaxis of experimentally induced streptococcal endocarditis. R Pujadas, E Escriva, J Jane, J Argimon, F Fernandez, P Fava, M Galera, and J Garau Services of Cardiology, Hospital Central Q.S. La Alianza, Barcelona, Spain. Abstract A regimen of a single intramuscular dose of penicillin G-streptomycin was compared with regimens of three oral doses of amoxicillin and two oral doses of penicillin V to prevent Streptococcus sanguis endocarditis in rabbits with experimentally induced valvular heart lesions. Challenge doses of 10(4), 10(6), and 10(8) CFU of a strain of S. sanguis highly tolerant to penicillin and amoxicillin were used. The combination of penicillin and streptomycin was the only regimen tested that provided full protection even against the highest inoculum concentration. A single oral dose of penicillin V (36 mg/kg) or amoxicillin (50 mg/kg), two oral doses of penicillin V (36 and 18 mg/kg with a 7-h interval between doses), or six oral doses of amoxicillin (50 mg/kg followed by 8.5 mg/kg at 8-h intervals) protected recipients of the lowest inoculum concentration; protection diminished with increasing inocula. In contrast, administration of two high oral doses of amoxicillin (50 mg/kg) with a 10-h interval between doses provided full protection against challenge doses of 10(4) and 10(6) CFU, preventing endocarditis in 10 (66%) of 15 recipients of 10(8) CFU. All regimens evaluated were highly effective in preventing endocarditis when rabbits were challenged with 10(4) CFU. The combination of penicillin and streptomycin was the best regimen tested. Administration of two high oral doses of amoxicillin (50 mg/kg) with a 10-h interval between doses led to significantly fewer infections when compared with the other oral regimens when rabbits were challenged with 10(6) and 10(8) CFU. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (914K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. These references are in PubMed. This may not be the complete list of references from this article. - Bernard JP, Francioli P, Glauser MP. Vancomycin prophylaxis of experimental Streptococcus sanguis. Inhibition of bacterial adherence rather than bacterial killing. J Clin Invest. 1981 Oct;68(4):1113–1116. [PubMed]
- Durack DT, Beeson PB. Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br J Exp Pathol. 1972 Feb;53(1):44–49. [PubMed]
- Durack DT, Petersdorf RG. Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens. J Clin Invest. 1973 Mar;52(3):592–598. [PubMed]
- Glauser MP, Bernard JP, Moreillon P, Francioli P. Successful single-dose amoxicillin prophylaxis against experimental streptococcal endocarditis: evidence for two mechanisms of protection. J Infect Dis. 1983 Mar;147(3):568–575. [PubMed]
- Glauser MP, Francioli P. Successful prophylaxis against experimental streptococcal endocarditis with bacteriostatic antibiotics. J Infect Dis. 1982 Dec;146(6):806–810. [PubMed]
- Hess J, Dankert J, Durack D. Significance of penicillin tolerance in vivo: prevention of experimental Streptococcus sanguis endocarditis. J Antimicrob Chemother. 1983 Jun;11(6):555–564. [PubMed]
- Holloway Y, Dankert J, Hess J. Penicillin tolerance and bacterial endocarditis. Lancet. 1980 Mar 15;1(8168 Pt 1):589–589. [PubMed]
- Horne D, Tomasz A. Lethal effect of a heterologous murein hydrolase on penicillin-treated Streptococcus sanguis. Antimicrob Agents Chemother. 1980 Feb;17(2):235–246. [PubMed]
- Lorian V, Zak O, Kunz S, Vaxelaire J. Staphylococcal endocarditis in rabbits treated with a low dose of cloxacillin. Antimicrob Agents Chemother. 1984 Mar;25(3):311–315. [PubMed]
- Pelletier LL, Jr, Durack DT, Petersdorf RG. Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis. J Clin Invest. 1975 Aug;56(2):319–330. [PubMed]
- Perlman BB, Freedman LR. Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart. Yale J Biol Med. 1971 Oct;44(2):206–213. [PubMed]
- Pujadas R, Escriva E, Jane J, Fernandez F, Fava P, Garau J. Comparative capacity of orally administered amoxicillin and parenterally administered penicillin-streptomycin to protect rabbits against experimentally induced streptococcal endocarditis. Antimicrob Agents Chemother. 1986 May;29(5):909–912. [PubMed]
- Pujadas R, Escriva E, Jane J, Galera MC, Fava P, Garau J, Mirelis B. Efficacy of orally administered penicillin V for prophylaxis of experimentally induced streptococcal endocarditis. Antimicrob Agents Chemother. 1987 Oct;31(10):1474–1477. [PubMed]
- Pulliam L, Inokuchi S, Hadley WK, Mills J. Penicillin tolerance in experimental streptococcal endocarditis. Lancet. 1979 Nov 3;2(8149):957. [PubMed]
- Shanson DC, Cannon P, Wilks M. Amoxycillin compared with penicillin V for the prophylaxis of dental bacteraemia. J Antimicrob Chemother. 1978 Sep;4(5):431–436. [PubMed]
- Shulman ST, Amren DP, Bisno AL, Dajani AS, Durack DT, Gerber MA, Kaplan EL, Millard HD, Sanders WE, Schwartz RH, et al. Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. Circulation. 1984 Dec;70(6):1123A–1127A. [PubMed]
- Wolfe JC, Johnson WD. Penicillin-sensitive streptococcal endocarditis. In-vitro and clinical observations on penicillin-streptomycin therapy. Ann Intern Med. 1974 Aug;81(2):178–181. [PubMed]
|